Diabetes Care Devices Market

The global diabetes care devices market is projected to reach 61.2 billion in 2030 from USD 34.3 billion in 2025, at a CAGR of 12.3% during the forecast period.

Several factors influence the diabetes care devices market. The two most significant ones are increasing diabetes rates and the expanding elderly population, which serve as main drivers for this sector. As more individuals are diagnosed and older adults face a higher risk of developing diabetes and its complications, the demand for precise monitoring and management tools like glucose meters, insulin delivery devices, and CGMs continues to grow, ensuring better disease control and improved quality of life.

Specific challenges may, however, hinder market expansion. The high cost of diabetes care devices presents a significant obstacle, as many patients—particularly in low- and middle-income regions—cannot afford advanced technologies such as CGMs and insulin pumps. Moreover, limited awareness in emerging markets about the benefits of regular monitoring and modern management solutions further restricts adoption, slowing market growth penetration.

Prominent players in the global diabetes care devices market include F. Hoffmann La-Roche Ltd. (Switzerland), Abbott Laboratories (US), Medtronic (Ireland), Dexcom (US), and Insulet Corporation (US).

To know about the assumptions considered for the study download the pdf brochure

Key players in the diabetes care devices market have adopted a combination of organic and inorganic growth strategies—such as product launches, acquisitions, collaborations, partnerships, agreements, and expansions—to strengthen their global presence and boost market share. These efforts have enabled them to expand geographically and distribute diabetes care devices across various regions.

In September 2024, Abbott Laboratories (US) announced the US availability of Lingo™, the company's first continuous glucose monitoring system available without a prescription.

In May 2023, F. Hoffmann-La Roche Ltd. (Switzerland) announced the launch of Accu-Check Active glucose meters in India.

F. Hoffmann-La Roche Ltd. (Switzerland) is a major global leader in the market for diabetes care devices. Roche operates through two segments: Pharmaceuticals and Diagnostics; the company is divided into four main areas: Centralized and Point of Care Solutions, Molecular Diagnostics, Tissue Diagnostics, and Diabetes Care. The Diabetes Care segment offers a variety of devices and solutions for effective diabetes management. A flagship product in this segment is the Accu-Chek blood glucose meter, widely recognized and clinically recommended for blood glucose monitoring. Accu-Chek devices are trusted by both patients and healthcare professionals for their accuracy, reliability, and strong clinical validation, making them a key part of Roche’s diabetes care portfolio and essential in managing diabetes effectively.

Abbott Laboratories (US), a leading global healthcare company founded in 1888 and headquartered in Illinois, US, is a major player in the diabetes care devices market. The company has a strong tradition of innovation by operating in multiple key sectors, including pharmaceuticals, nutrition, diagnostics, and medical technologies. A core part of its success is its leadership in diabetes care. Through its flagship FreeStyle brand, Abbott provides a range of advanced continuous glucose monitoring (CGM) and blood glucose systems, most notably the FreeStyle Libre, along with essential accessories and digital health tools for patients around the world. With a workforce exceeding 114,000 and a presence in over 160 countries, the company uses its diverse portfolio and extensive global reach to stay a highly trusted name in health and wellness.

Medtronic (Ireland) is a global leader in medical technology and has been at the forefront of health technology since its founding in 1949. It also controlled a significant share of the diabetes care devices market in 2024. Headquartered in Dublin, Ireland, the company’s core mission is to alleviate pain, restore health, and extend life. With operations in over 150 countries and a workforce of more than 95,000 employees, Medtronic ranks among the world’s largest medical tech firms. It organizes its extensive portfolio into four main divisions: Cardiovascular, Diabetes, Medical Surgical, and Neuroscience, reinforcing its position as a trusted industry leader. Medtronic's diabetes division is a key part of its business, focusing on automated insulin delivery (AID) and glucose monitoring. The company pioneered the artificial pancreas concept with its MiniMed™ insulin pumps and Guardian™ CGM systems. By developing a unified, closed-loop ecosystem, the segment aims to simplify diabetes management and lessen the daily burden for patients relying on these technologies for insulin.

MARKET RANKING

In the global diabetes care devices market, the competitive landscape is influenced by a mix of leading multinational corporations and strong regional players. F. Hoffmann-La Roche Ltd (Switzerland) maintains a leading position, supported by its extensive product portfolio, worldwide distribution network, and trusted brand reputation. The company has maintained its leadership through ongoing product innovation and consumer-focused marketing. Abbott Laboratories (US) is another major player, especially in North America and international markets. Medtronic (Ireland) also holds a significant share, offering a variety of products. Other notable companies include Dexcom (US) and Insulet Corporation (US), which contribute to market diversity through innovative formulations and extensive retail reach. Collectively, these companies dominate the diabetes care devices industry, setting standards in formulation science, consumer confidence, and global presence.

Related Reports:

Diabetes Care Devices Market by Product Type (Blood Glucose Monitoring (CGM), Insulin Delivery Devices (Insulin Pumps (Tethered), Insulin Pens, Pen Needles), Application) Disease Type (Type 1, Type 2), End User (Homecare/Self) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com